Expanding Knowledge on the Genetics of Hypertrophic Cardiomyopathy: A New Prevalent Intermediate-Effect Variant in the FHOD3 Gene
• The intermediate-effect variant p.Arg637Gln in the FHOD3 gene has been identified to increase the [...]
Jan
Owl Metabolomics and Health in Code sign an agreement to expand their service offerings in the field of genomics, proteomics and metabolomics
Madrid, November, 8, 2023. OWL Metabolomics and Health in Code, leaders in the omics sciences, [...]
Nov
Massive Bio and Health in Code collaborate to enhance personalized oncology treatment through advanced genomic testing
Madrid, October 31, 2023. Personalized medicine leading companies, Massive Bio and Health in Code, have [...]
Oct
Health in Code acquires Genologica and strengthens its leading position in the Spanish genetics market
• Both companies have over 15 years of experience in the field of clinical genetics [...]
Jul
Dr. Charlotte Dravet: “Knowing the genetic origin of an epilepsy often allows to discard treatments such as surgery which should be an error”
• Dravet syndrome discoverer, Dr. Charlotte Dravet, highlights importance of genetic studies in the improvement [...]
Jun
Health in Code installs the first NovaSeq X Plus in Spain and consolidates its leadership in terms of genomic sequencing capacity by investing in whole-genome sequencing
We are immersed in the era of genomics. Science-based companies in the genomic diagnostics field [...]
Jun